Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
Natick man William “Joey” Howard, 74, died from lung cancer and esophageal cancer in May of 2023 — a “premature and ...
Adenocarcinoma is the most common form of lung cancer ... the cancer cells in the bones are actually non-small cell lung cancer cells. The disease is metastatic non-small cell lung cancer, not bone ...
The Print on MSN2d
PGIMER report bats for new-age targeted lung cancer therapies to be included in AB-PMJAYReport commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...
Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.
BioAtla is laying off 30% of staff as the biotech searches for partners for some of its conditionally active biologic (CAB) ...
Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...
Mutant KRAS in ctDNA in patients with localized pancreatic cancer was shown to be a biomarker for metastatic progression and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback